Basilea Pharmaceutica AG (BPMUF)
76.25
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Basilea Pharmaceutica SG&A Expense (TTM) : 45.60M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.60M |
| December 31, 2025 | 42.96M |
| June 30, 2025 | 38.79M |
| December 31, 2024 | 35.83M |
| June 30, 2024 | 36.69M |
| December 31, 2023 | 37.61M |
| June 30, 2023 | 33.88M |
| December 31, 2022 | 32.28M |
| June 30, 2022 | 33.26M |
| December 31, 2021 | 32.51M |
| June 30, 2021 | 32.21M |
| December 31, 2020 | 31.38M |
| June 30, 2020 | 29.01M |
| December 31, 2019 | 30.22M |
| June 30, 2019 | 31.79M |
| December 31, 2018 | 32.11M |
| June 30, 2018 | 36.22M |
| December 31, 2017 | 53.85M |
| June 30, 2017 | 63.73M |
| December 31, 2016 | 56.92M |
| June 30, 2016 | 58.41M |
| December 31, 2015 | 56.25M |
| June 30, 2015 | 44.07M |
| Date | Value |
|---|---|
| December 31, 2014 | 32.75M |
| June 30, 2014 | 24.77M |
| December 31, 2013 | 22.97M |
| June 30, 2013 | 26.36M |
| December 31, 2012 | 45.27M |
| June 30, 2012 | 124.63M |
| December 31, 2011 | 123.38M |
| June 30, 2011 | 64.46M |
| December 31, 2010 | 73.86M |
| June 30, 2010 | 103.95M |
| December 31, 2009 | 104.26M |
| June 30, 2009 | 99.34M |
| December 31, 2008 | 87.92M |
| June 30, 2008 | 51.85M |
| December 31, 2007 | 32.69M |
| June 30, 2007 | 18.94M |
| December 31, 2006 | 10.13M |
| June 30, 2006 | 6.942M |
| December 31, 2005 | 6.942M |
| June 30, 2005 | 5.805M |
| December 31, 2004 | 5.805M |
| June 30, 2004 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Santhera Pharmaceuticals Holding AG | 18.92M |
| BeOne Medicines Ltd. | 2.238B |
| AC Immune SA | 19.51M |
| CRISPR Therapeutics AG | 70.07M |
| Idorsia Ltd. | 264.55M |